The p53 codon 72 polymorphism and the risk of oral cancer in a Chinese han population

Genetic Testing and Molecular Biomarkers

Volumn 16, Issue 9, 2012, Pages 1149-1152

  Jing, Guangping ^a   Lv, Kewen ^a   Jiao, Xiaohui ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; PROLINE;

ADULT; ARTICLE; CANCER PATIENT; CANCER RISK; CANCER STAGING; CANCER SUSCEPTIBILITY; CHINESE; CODON; CONTROLLED STUDY; DNA ISOLATION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HISTOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; P53 GENE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK REDUCTION; TUMOR DIFFERENTIATION; TUMOR SUPPRESSOR GENE;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CODON; FEMALE; GENE FREQUENCY; GENES, P53; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; POLYMORPHISM, GENETIC; RISK FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84866237344     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2012.0138     Document Type: Article

References (30)

1. Balaji L, Lakkakula BV, Krishna BS, et al. (2011) Lack of association of EPHX1 genotypes and haplotypes with oral cancer in South Indians. Genet Test Mol Biomarkers 15:595-599.
2. Bau DT, Tsai MH, Lo YL, et al. (2007) Association of p53 and p21(CDKN1A/WAF1/CIP1) polymorphisms with oral cancer in Taiwan patients. Anticancer Res 27:1559-1564.
3. Buchman VL, Chumakov PM, Ninkina NN, et al. (1988) A variation in the structure of the protein-coding region of the human p53 gene. Gene 70:245-252.
4. Chen X, Sturgis EM, El-Naggar AK, et al. (2008) Combined effects of the p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms on the risk of HPV16-associated oral cancer in never-smokers. Carcinogenesis 29:2120-2125.
5. Dumont P, Leu JI, Della Pietra AC, 3rd, et al. (2003) The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33:357-365. (Pubitemid 36278852)
6. Gomez I, Seoane J, Varela-Centelles P, et al. (2009) Is diagnostic delay related to advanced-stage oral cancer? A meta-analysis. Eur J Oral Sci 117:541-546.
7. Hamel N, Black MJ, Ghadirian P, et al. (2000) No association between P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck. Br J Cancer 82:757-759. (Pubitemid 30085220)
8. Hollstein M, Sidransky D, Vogelstein B, et al. (1991) p53 mutations in human cancers. Science 253:49-53. (Pubitemid 21917115)
9. Jee SH, Won SY, Yun JE, et al. (2004) Polymorphism p53 codon-72 and invasive cervical cancer:a meta-analysis. Int J Gynaecol Obstet 85:301-308. (Pubitemid 38622573)
10. Jiang DK, Ren WH, Yao L, et al. (2010) Meta-analysis of association between TP53 Arg72Pro polymorphism and bladder cancer risk. Urology 76:765, e761-e767.
11. Katiyar S, Thelma BK, Murthy NS, et al. (2003) Polymorphism of the p53 codon 72 Arg/Pro and the risk of HPV type 16/18-associated cervical and oral cancer in India. Mol Cell Biochem 252:117-124. (Pubitemid 37220740)
12. Kietthubthew S, Sriplung H, AuWW, et al. (2003) The p53 codon 72 polymorphism and risk of oral cancer in Southern Thailand. Asian Pac J Cancer Prev 4:209-214.
13. McWilliams JE, Evans AJ, Beer TM, et al. (2000) Genetic polymorphisms in head and neck cancer risk. Head Neck 22:609-617. (Pubitemid 30663077)
14. Misra C, Majumder M, Bajaj S, et al. (2009) Polymorphisms at p53, p73, and MDM2 loci modulate the risk of tobacco associated leukoplakia and oral cancer. Mol Carcinog 48:790-800.
15. Nagpal JK, Patnaik S, Das BR (2002) Prevalence of high-risk human papilloma virus types and its association with P53 codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (OSCC) patients of Eastern India. Int J Cancer 97:649-653. (Pubitemid 34087805)
16. Niu Y, Hu Y, Wu M, et al. (2012) CYP2E1 Rsa I/Pst I polymorphism contributes to oral cancer susceptibility:a meta-analysis. Mol Biol Rep 39:607-612.
17. Petersen PE (2009) Oral cancer prevention and control-the approach of the World Health Organization. Oral Oncol 45:454-460.
18. Pim D, Banks L (2004) p53 polymorphic variants at codon 72 exert different effects on cell cycle progression. Int J Cancer 108:196-199. (Pubitemid 37541770)
19. Shen H, Zheng Y, Sturgis EM, et al. (2002) P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck:a case-control study. Cancer Lett 183:123-130. (Pubitemid 34628415)
20. Summersgill KF, Smith EM, Kirchner HL, et al. (2000) p53 polymorphism, human papillomavirus infection in the oral cavity, and oral cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90:334-339.
21. Tandle AT, Sanghvi V, Saranath D (2001) Determination of p53 genotypes in oral cancer patients from India. Br J Cancer 84:739-742. (Pubitemid 32275644)
22. Thomas M, Kalita A, Labrecque S, et al. (1999) Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 19:1092-1100. (Pubitemid 29046852)
23. Yook JI, Kim J (1998) Expression of p21WAF1/CIP1 is unrelated to p53 tumour suppressor gene status in oral squamous cell carcinomas. Oral Oncol 34:198-203. (Pubitemid 28267171)
24. Zhang R, Chen W, Zhang W, et al. (2011a) Genetic polymorphisms of p53 codon 72 and bladder cancer susceptibility:a hospital-based case-control study. Genet Test Mol Biomarkers 15:337-341.
25. Zhang Z, Wang M, Wu D, et al. (2010) P53 codon 72 polymorphism contributes to breast cancer risk:a meta-analysis based on 39 case-control studies. Breast Cancer Res Treat 120:509-517.
26. Zhang ZJ, Hao K, Shi R, et al. (2011b) Glutathione S-transferase M1 (GSTM1) and glutathione S-transferase T1 (GSTT1) null polymorphisms, smoking, and their interaction in oral cancer:a HuGE review and meta-analysis. Am J Epidemiol 173:847-857.
27. Zhou C, Zhou Y, Li J, et al. (2009) The Arg194Trp polymorphism in the X-ray repair cross-complementing group 1 gene as a potential risk factor of oral cancer:a meta-analysis. Tohoku J Exp Med 219:43-51.
28. Zhou Y, Li N, Zhuang W, et al. (2007) P53 codon 72 polymorphism and gastric cancer:a meta-analysis of the literature. Int J Cancer 121:1481-1486. (Pubitemid 47328706)
29. Zhou Y, Li N, Zhuang W, et al. (2010) p53 Codon 72 polymorphism and gastric cancer risk in a Chinese Han population. Genet Test Mol Biomarkers 14:829-833.
30. Zhuo W, Wang Y, Zhuo X, et al. (2009) CYP1A1 and GSTM1 polymorphisms and oral cancer risk:association studies via evidence-based meta-analyses. Cancer Invest 27:86-95.